Theravance (THRX) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Theravance (THRX) Price Target Lifted to $17 at BofA/Merrill Lynch
February 19, 2015 7:23 AM ESTBofA/Merrill Lynch raised its price target on Theravance Inc. (NASDAQ: THRX) to $17.00 (from $15.00) following Q4 results, but maintained a Neutral rating. The firm notes US and ex-US trends are strengthening.
Analyst Steve Byrne raised their ex-US peak to $1.2 billion from $1... More
